Greyson International Inc. receives industry expert validation regarding pharmaceutical patent cliff panic.

COCONUT CREEK, Fla. – July 22, 2013- Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that talks with patent law firm Lerner Greenberg Stemer LLP resulted in across the board agreement with Greyson’s plan to help save and stave the potential $90+ billion loss in the pharmaceutical market.

Large pharmaceutical companies are facing a so-called “patent cliff”, whereby brand names drugs, once having delivered steady sales and profits are losing, or have already lost, their patent protection.  Johnson and Johnson (NYSE:JNJ) has had three blockbuster drug patents expire in the last two years, Eli Lilly’s (NYSE:LLY) Cymbalta loses its patent at the end of 2013, and Pfizer (NYSE:PFE) recently attained a short extension on multibillion-dollar Celebrex which expires in Dec. 2015.

Lerner Greenberg Stemer LLP patent law firm for the world’s largest multinational corporations concur with Greyson’s plan to utilize their patented Trilexon® trans-dermal topical delivery system in several ways. “Leveraging our technology, large pharmaceutical companies can potentially reformulate their drugs to be delivered topically instead of orally, extend patent lives, and/or create new patents quickly under the Greyson umbrella” said Harvey Tauman, CEO of Greyson International Inc. “Greyson International, in addition to being debt free, has invested millions over a period of about 20 years culminating to the point whereby preparation is meeting opportunity.”

Currently Greyson International has anchored a large manufacturer, added two prominent physicians as consultants, and recruited top industry beauty consultants for Greyson Skincare® with Trilexon® technology.  Their new spokesperson and brand manager, Tia Castle is preparing to launch Greyson Skincare line on network shopping television toward the fourth quarter of 2013.  Greyson is open to adding new talent to the managerial team as it rapidly expands to meet market demands.  All inquiries may contact Harvey Tauman.

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

 

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Greyson International Inc. builds talent pool in preparation for resolving patent cliff panic

COCONUT CREEK, Fla. – July 2, 2013- Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it recruited Tia Castle for the position of Brand Manager and Beauty Spokes Person for Greyson Skincare with Trilexon® technology.

Tia brings more than 15 years’ experience in both pharmaceutical sales and marketing with drug giant Johnson & Johnson (J&J). She is also an established on-air TV and film personality”, said Harvey Tauman, CEO of Greyson Inc.  Ms. Castle’s immediate role will be to manage the launch of Greyson Skincare on shopping networks, targeted for later this year, and appear as the on-air spokesperson. “I am excited to come on board full time, as I believe in Greyson’s ability to become a worldwide leader in skincare and pharmaceuticals. The potential to help companies stave off and recover from the ‘patent cliff’ is an enormous opportunity that needs immediate implementation,” said Tia Castle. “

The “patent cliff” is a big pharma company problem whereby brand names drugs that have delivered steady sales and profits are losing their patent protection. Greyson’s next news release will be detailing how their Trilexon® delivery system will give hope to the industry regarding the potential $90 billion loss.

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer

Greyson International Inc. Releases Animated Motion Video Explaining their Patented Trilexon® Topical Delivery System

COCONUT CREEK, Fla. – Aug. 7, 2013- Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today made public on a YouTube video detailed information including an animated motion graphic explaining Trilexon® technology.  Video link: http://bit.ly/Trilexon

“I’m very proud to release this video. It’s an education regarding the applications and enormous potential of Trilexon®, it gives an intimate glimpse into what Greyson International has embarked upon and, it has enabled me to speak from my heart directly to the public” said Harvey Tauman, CEO of Greyson International Inc.

Greyson Int. is currently revamping their website to reflect initiatives stated in the video but will remain invisible on the website until all information is complete. A shareholder conference call is being announced shortly.

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

Greyson International Inc. Garners Investor Interest in a series of Financial Presentations Pre-empting an Investor Conference

Greyson International Inc. Garners Investor Interest in a series of Financial Presentations Pre-empting an Investor Conference

COCONUT CREEK, Fl. – Nov. 6, 2013- Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented trans-dermal and topical delivery emulsion targeting the multi-billion dollar anti-aging and OTC pharmaceutical industrieTia Headshots, unveiled details about the technology as well as business plans and market potential in a three-city series of financial presentations. The multimedia presentation delivered by Greyson Marketing Director, Tia Castle reveals the science behind Trilexon® technology and explains the vast applications in the pharmaceutical and anti-aging market.  A sixty-second preview clip of the presentation is also available which highlights how Trilexon® increases dermal permeation of anti-aging and/or topical pharmaceutical ingredients.

Tony Schor of Investor Awareness, director of the tri-city series remarked, “Now that the Company has a patent for Trilexon and is prepared to launch product, we felt it was the right timing to begin to tell the Greyson story to the financial community thru a series of financial presentations. We look forward to continuing our efforts in generating exposure and awareness on behalf of Greyson across the Country.”

“I felt this presentation explains the technology to both a lay and medical audience. But more importantly, I saw the light bulb go on when the audience of investors realized the enormous potential” said Tia Castle, Greyson International Marketing Director and Spokeswoman. She also added that an investor conference call will take place on Nov. 21, 2013 at 4:15 EST.  A reminder press release will be issued to announce details and the call in phone number.

 

Harvey Tauman, CEO of Greyson Inc. commented, “Our diligence in attaining a patent and test marketing Trilexon® has us on the verge of exploding into the market place as supported by the science you will see explained in this presentation. I am very proud to announce that our team will launch the new product line in the first quarter of 2014.” Greyson International recently hired consultant Joe Bovino, Esq., to head their pharmaceutical licensing division.  Joe has extensive relationships in the pharmaceutical industry having brokered many licensing deals for various companies.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Greyson International Inc.
Harvey Tauman, 954-482-0497
Chief Executive Officer
Harvey@greysonintl.com

Greyson International Inc. to Hold Investor Conference Call on Thursday, November 21, 2013

Greyson International Inc. to Hold Investor Conference Call on Thursday, November 21, 2013

Coconut Creek, Fla. – November 19, 2013 – Greyson International, Inc. (OTC Pink Sheets: GYSN), developer of an innovative-patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it would be holding an investor conference call on Thursday, November 21, 2013, at 4:15 pm EDT. The conference call dial in number is 530-881-1300 and the Participant Access Code is 934487. The recorded version of the conference call will be available for playback after the call is concluded. Dial 530-881-1399 to listen.

“Our company has laid the foundation and set into motion the launch of Greyson Skincare, licensing deals and pharmaceutical joint ventures. I’m looking forward to giving details on these activities,” said Harvey Tauman, CEO of Greyson International Inc. “In addition, I’m looking forward to discussing our future plans on this call, as we bring our patented Trilexon trans-dermal delivery system to market and ultimately unlock significant value for our shareholders in 2014 and beyond.”

In preparation you may view the new videos on the Greyson website.

Welcome (Company & Technology Overview)

Detailed explanation of Trilexon® technology (second video)

Live Financial Investor Presentation Oct. 2013

 

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® has benefits in the medical field where it is important to deliver topical active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.comand join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Greyson International Inc. Hires TransMedia Group To Deliver Its Powerful Trilexon Story

BOCA RATON, Fla., Feb. 10, 2014 /PRNewswire/ — Greyson International Inc. (OTC Pink Sheets: GYSN) has retained TransMedia Group to introduce its patented transdermal delivery system Trilexon (www.greysonintl.com)focusing on both the beauty and pharma sectors in delivering anti-aging and prescription ingredients through the skin for maximum effectiveness.

TransMedia (www.transmediagroup.com) said it will publicize how Trilexon can resuscitate expiring pharmaceutical patents and save sales that otherwise would be lost over an ever widening, precipitous patent cliff.  TransMedia said it also will publicize a skin care line that Greyson plans to launch in the near future.  The industry stands to lose an estimated $90 billion from expired patents.

“When patents expire, companies face steep competition, causing revenues to drop off along with the value of their stock,” said Greyson Legal consultant Joe Bovino, “but Trilexon is a game changer as it will extend patent life of medications and other products.”

According to Greyson’s President and CEO Harvey Tauman, Trilexon enables active ingredients to be delivered topically instead of through the blood stream via swallowing a pill.

“Our publicity will show Trilexon enables ingredients to last longer and have greater impact as they’re contained in a unique emulsion.  Once water insoluble Trilexon is applied to skin, it acts as a breathable environmental dome, sealing in moisture and balancing pH,” said TransMedia CEO Tom Madden.

In his illustrious 40-year career in the cosmetics industry, Tauman was twice responsible for triple stock splits in companies he led and scoring a one-day record $2 million in sales on QVC, culminating in over $100 million in sales of his past cosmetic products, said Madden.

Greyson’s Brand Manager Tia Castle said that within Trilexon’s unique environment, actives such as medications, antioxidants and vitamins are able to release their full potential.

TransMedia said its publicity will show how Trilexon has the potential to reduce drug interaction and addictiveness and provide a power boost for skin and hair and long lasting SPF’s.

TransMedia will highlight how Greyson VP Mukeh Prasad assisted the late Charley Fox in developing Trilexon and how Fox believed Trilexon will help everyone in a way never thought possible.

Media contact: Iviani Figueroa 561-750-9800 x233; iviani@transmediagroup.com.

SOURCE TransMedia Group

Greyson International, Inc. (OTC Pink Sheets: GYSN) Announces Agreement With The Shopping Channel To Offer Its Revolutionary New Skin Care Line For Sale In Canada

Greyson International, Inc. (OTC Pink Sheets: GYSN) Announces Agreement With The Shopping Channel To Offer Its Revolutionary New Skin Care Line For Sale In Canada

COCONUT CREEK, Fl., April 21, 2014 /PRNewswire/ — Greyson International, Inc. (OTC Pink Sheets: GYSN) announced today one of the leading interactive multi-channel retailers in North America, The Shopping Channel of Canada (tsc.ca), will offer for sale Greyson’s innovative new skin care line containing its patented transdermal delivery system Trilexon®  (www.greysonintl.com).

“This presents us with a marvelous sales opportunity for our company by offering consumers throughout Canada Greyson Skincare products containing our revolutionary delivery system,” said Greyson’s CEO Harvey Tauman.  The Trilexon Delivery System allows pharmaceutical and anti-aging ingredients to be released in the skin for extended periods for maximum effectiveness.

Greyson will offer for sale on The Shopping Channel its Perfect Balance Moisturizer, which minimizes fine lines and wrinkles, lifts skin and enforces the anti-oxidant barrier layer on skin by keeping the pH at 4.5-5. As well as its Clean Complex Foaming Cleanser and Pore Diminishing Toner, as great results begin with the foundation of a cleanser and toner. Trilexon’s cleanser and toner are engineered to clean without stripping, balances the pH to prepare the skin to readily accept.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our web site; http://greysonintl.com and join the Greyson International’s Face book page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contacts:

Greyson International Inc., Harvey Tauman, 954-482-0497,Chief Executive Officer, Harvey@greysonintl.com

Media contact: Abigail Blake 561-750-9800 x 2290; abby@transmediagroup.com.

SOURCE Greyson International, Inc.

How Companies Can Avoid 'Patent Cliff' With Revolutionary Trilexon® Delivery System

How Companies Can Avoid ‘Patent Cliff’ With Revolutionary Trilexon® Delivery System

 

NEW YORK, April 28, 2014 /PRNewswire/ — Harvey Tauman, CEO of Greyson International, Inc. (otc pink sheets: GYSN) is back in stride as he takes his Trilexon® message directly to Wall Street on www.Wall-Street.com with the same robust style that made him one of QVC’s most prolific presenters, setting $100 million sales records.

Tauman’s video presentation debuts today on Wall-Street.com in which he explains how the Trilexon Delivery System can save pharmaceutical products from cascading off “the patent cliff.” Wall-Street.com recognizes exceptional microcap companies and is a premier financial center for information.

“I want Wall Street to know what we have here,” says Tauman enthusiastically, explaining how Trilexon can extend patent life by adding the revolutionary transdermal delivery system to products.

Tauman’s message is fresh on the heels of his announcement last week that one of the leading interactive multi-channel retailers in North America, The Shopping Channel of Canada (tsc.ca), will offer for sale Greyson’s innovative new skin care line containing its patented transdermal delivery system Trilexon (www.greysonintl.com).  “We now have a way for pharmaceutical and anti-aging ingredients to be released in the skin for extended periods for maximum effectiveness.

Greyson line includes Perfect Balance Moisturizer, which minimizes fine lines and wrinkles, lifts skin and strengthens the barrier layer on skin by keeping pH at 4.5-5. In this pH range barrier layer repairs itself and the skin readily accepts the active ingredients. Also a Clean Complex Foaming Cleanser and Pore Diminishing Toner, providing foundation of a cleanser and toner engineered to clean without stripping the essential oils from our skin, balances the pH to prepare the skin to readily accept the moisturizing ingredients.

About Greyson International, Inc. Trilexon® is a registered trademark of Greyson International Inc. http://greysonintl.com. Facebook page:http://www.facebook.com/GreysonInternationalInc .
This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements resulting from a variety of factors including, but not limited to, risks and uncertainties associated with Greyson’s financial condition, its ability to sell products or compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contacts: Greyson International Inc., Harvey Tauman, 954-482-0497,Chief Executive Officer, Harvey@greysonintl.com

Media contact: Abigail Blake 561-750-9800 x2290; abby@transmediagroup.com.

SOURCE Greyson International, Inc.

With Start Of Sales Of Anti-Aging Skin Care At www.greysonintl.com, Greyson International, Inc. (OTC Pink Sheets: GYSN) CEO Keeps A Promise To A Cosmetics Titan

With Start Of Sales Of Anti-Aging Skin Care At www.greysonintl.com, Greyson International, Inc. (OTC Pink Sheets: GYSN) CEO Keeps A Promise To A Cosmetics Titan

COCONUT CREEK, Fla., July 8, 2014 /PRNewswire/ — With the fulfillment of orders this week at (www.greysonintl.com) for the Greyson Skin Care Three-Piece Kit with the revolutionary Trilexon® topical delivery system, Harvey Tauman keeps a promise he made to cosmetics industry titan, the late Charlie Fox.

Fox was the inventive chemist who developed the unique delivery system, which Tauman, CEO of Greyson International, Inc. (OTC Pink Sheets: GYSN) calls “the smart phone of the cosmetics industry.”

Tauman promised Fox, one of Warner-Lamberts’ most prolific product developers, that his dream for Trilexon® helping people worldwide would come true.

Greyson owns and secured a patent on these products containing Trilexon®, which are selling on www.greysonintl.com after years of development.

“Trilexon® will help people rejuvenate their skin like never before,” said Tauman who was founder and CEO of Hydron Technologies, Inc. when its stock on NASDAQ surged from 37 1/2 cents to $14.75, making it the biggest percentage gainer in 1983.

In April 1994, Tauman was chief spokesman of cosmetic and personal care products on QVC shopping channel, where he broke sales records, including $2.1M in one day of Hydron’s products.

The Greyson’s three-piece Skincare Kit with Trilexon® on sale for $99 contains a Perfect Balance Moisturizer, Clean Complex Foaming Cleanser and Pore Diminishing Toner each with Trilexon®, which releases pharmaceutical and anti-aging ingredients on the skin over extended periods. This technology supports the skins barrier layer which maintains a specific pH level on the skin and reduced moisture evaporation, thus promoting the ingredient penetration. Also, Trilexon’s® extended delivery of ingredients into the skin lasts longer.

In independent third party laboratory tests, performed by Peter T. Pugliese, M.D. and Zoe Diana Draelos, M.D., Trilexon® proved to deliver active ingredients at a consistent rate for extended periods. Unlike most emulsion systems which continue to emulsify once applied on the skin and breaks down the barrier layer, the Greyson’s Trilexon® Delivery System stops emulsifying the essential oils and keeps the barrier layer intact.

“Trilexon® is the single most important development in cosmetics in the past 50 years,” said Tauman.

About Greyson International, Inc. Trilexon® is a registered trademark of Greyson International, Inc. http://greysonintl.com. Facebook page:http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements resulting from a variety of factors including, but not limited to, risks and uncertainties associated with Greyson’s financial condition, its ability to sell products or compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission

Contacts: Greyson International, Inc., Harvey Tauman, 954-482-0497,Chief Executive Officer, Harvey@greysonintl.com, Media contact: Adrienne Mazzone 561-750-9800 x2270; amazzone@transmediagroup.com

Greyson International, Inc. Announces the Untimely Death of Its Chairman and CEO

Greyson International, Inc. Announces the Untimely Death of Its Chairman and CEO

COCONUT CREEK, Fla., July 29, 2014 /PRNewswire/ — Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that Harvey Tauman, the Company’s Chairman and CEO, passed away this morning unexpectedly. Mr. Tauman was 73 years old. He had been hospitalized recently for treatment of respiratory failure.

The Board of Directors issued the following statement: “We are greatly saddened by the passing of Harvey Tauman.  The Company’s directors and employees, as well as the many people he worked with over the years, mourn his loss.  We extend our sympathies to his family.”

C. Mukesh Prasad, the Company’s Director and Vice-President will preside as Chairman and CEO over the interim period.

Chaudhury Mukesh Prasad, Vice President 
Mr. Prasad has served as the Vice President of Operations for Greyson International, Inc. since 2003. He is now serving on the Board of Directors of the Company as well as Corporate Secretary and Executive Vice President. Previously employed for 25 years at Hydron Technologies, Inc., Mr. Prasad held the positions of Controller, Vice President, Corp. Secretary, and member of the board as well as other various operational roles.

Mr. Prasad brings significant hands on managerial experience to Greyson International, Inc.  He assists the Company with product development, production and launch of various skin care and hair care products.  He has extensive experience in business operations, accounting, purchasing, manufacturing, warehousing, fulfillment center, and human resources.  Mr. Prasad studied Physics, Chemistry and Math at collage in India and studied accounting, and management in USA.  He is also an active member of the Society of Cosmetic Chemist.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact
Greyson International Inc.
C. Mukesh Prasad, 954-482-0497
Interim Chief Executive Officer